Ranbaxy Labs - Q2CY2013 Result Preview - Angel Broking

Ranbaxy is expected to post a decline of 10.2% in sales to Rs. 2,850cr during 2QCY2013. Its OPM is expected to come in at 10.5% Vs 14.4% in 2QCY2012. However, the net profit is likely to come in at Rs. 304cr, Vs Rs. 51cr during the corresponding period of last year. We maintain our buy on the stock.

Source : Equity Bulls

Keywords